According to Vasta Platform's latest financial reports the company's current earnings (TTM) are $30.75 M. In 2022 the company made an earning of $30.67 M an increase over its 2021 earnings that were of -$11.91 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $30.75 M | 0.26% |
2022 | $30.67 M | -357.71% |
2021 | -$11.91 M | -253.81% |
2020 | $7.73 M | -64.04% |
2019 | $21.51 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Verastem Oncology
VSTM | -$87.37 M | -384.07% | ๐บ๐ธ USA |
Spectrum Pharmaceuticals
SPPI | -$61.89 M | -301.20% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | -$0.65 B | -2,193.30% | ๐บ๐ธ USA |